Search

everythinglearnresearchcommunity

for

Search:↓

Women with PCOS have higher levels of certain androgens, which are good at predicting excess hair growth.

Metabolic syndrome and PCOS are related but separate conditions, with metabolic syndrome increasing the risk of heart disease and diabetes.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Androstanediol glucuronide is a reliable marker for hirsutism in women.

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.

Insulin-lowering medications show promise for PCOS symptoms but can't be the main treatment yet due to limited long-term research.

Measuring reproductive hormones in brown bear hair could help identify their sex and reproductive state, but better collection methods or lab techniques are needed.

Testosterone therapy can improve sexual desire and function in postmenopausal women but should be used cautiously and not based solely on testosterone levels.

Both genetic and lifestyle factors significantly affect female hair loss.

Women aged 21-26 have a higher rate of PCOS.

Anagen grow may effectively treat hair loss by blocking testosterone and reducing enzyme activity.

Testosterone with finasteride improved muscle and bone health in men with spinal cord injury.

Androgen replacement therapy can improve libido and mood in women with severe androgen deficiency, but more research is needed on its long-term safety.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.

Women with PCOS are more than twice as likely to develop nonalcoholic fatty liver disease.

Testosterone therapy can help improve mood, sexual function, and bone health in women with low androgen levels, but more research is needed to establish safe and effective guidelines.

Lifestyle changes can improve body composition, excess male hormone levels, and insulin resistance in women with PCOS.

New treatments for male hypogonadism are effective and should be personalized.

Testosterone may slow down wound healing and increase inflammation.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

DHT, a testosterone byproduct, causes male pattern baldness.

Men with male-pattern baldness have more androgen receptors in their scalp's oil glands, which may contribute to hair loss.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

The document concludes that using LC-MS/MS for measuring androgens is more accurate than older methods, but it needs careful validation and standardized references to be most effective.

Menopausal women have higher androgen levels, which can cause symptoms like facial hair growth and low sexual desire.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

Red deer only have androgen receptors in neck hair cells for mane growth during breeding season.

People with hair loss may have different levels of certain hormones due to changes in hormone processing.